Akebia Therapeutics, Inc. (AKBA)

NASDAQ: AKBA · Real-Time Price · USD

1.250

+0.030 (2.46%)

At close: Mar 4, 2026, 4:00 PM EST

1.258

+0.008 (0.66%)

After-hours: Mar 4, 2026, 4:48 PM EST

Akebia Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	184.84	51.87	42.93	90.47	149.8
Cash & Short-Term Investments	184.84	51.87	42.93	90.47	149.8
Cash Growth	256.36%	20.84%	-52.55%	-39.61%	-44.25%
Accounts Receivable	47.03	34.37	39.29	40.28	51.58
Inventory	15.61	16.24	15.69	21.57	36.63
Other Current Assets	5.47	11.35	20.24	32.86	33.14
Total Current Assets	252.96	113.83	118.15	185.18	271.15
Net Property, Plant & Equipment	4.89	10.42	16.05	34.37	40.61
Other Intangible Assets	-	-	36.04	72.08	108.13
Goodwill	59.04	59.04	59.04	59.04	59.04
Other Long-Term Assets	59.68	37.38	12.42	5.37	50.42
Total Assets	376.57	220.67	241.7	356.05	529.35
Accounts Payable	21.19	15.18	14.64	18.02	33.59
Accrued Expenses	121.72	63.46	67.74	75.78	109.01
Current Portion of Long-Term Debt	-	-	17.5	32	97.54
Unearned Revenue	2.68	-	-	3.74	20.91
Other Current Liabilities	17.36	2.27	-	-	-
Total Current Liabilities	162.94	80.91	99.87	129.54	261.05
Long-Term Debt	48.25	38.69	17.18	34.08	-
Long-Term Leases	-	3.55	8.95	28.96	33.7
Other Long-Term Liabilities	132.77	146.7	146.29	158.25	160.59
Total Long-Term Liabilities	181.02	188.94	172.42	221.29	194.29
Total Liabilities	343.96	269.86	272.29	350.82	455.34
Common Stock	0	0	0	0	0
Additional Paid-in Capital	1,716	1,629	1,578	1,562	1,537
Accumulated Other Comprehensive Income	0.01	0.01	0.01	0.01	0.01
Retained Earnings	-1,684	-1,678	-1,609	-1,557	-1,463
Shareholders' Equity	32.61	-49.19	-30.58	5.23	74.01
Total Liabilities & Equity	376.57	220.67	241.7	356.05	529.35
Total Debt	48.25	42.24	43.63	95.04	131.25
Net Cash (Debt)	136.59	9.63	-0.71	-4.57	18.55
Net Cash Growth	1318.42%	-	-	-	-87.44%
Net Cash Per Share	0.53	0.05	-0.00	-0.03	0.11
Book Value	32.61	-49.19	-30.58	5.23	74.01
Book Value Per Share	0.13	-0.23	-0.16	0.03	0.45
Tangible Book Value	-26.43	-108.23	-125.67	-125.9	-93.16
Tangible Book Value Per Share	-0.10	-0.51	-0.67	-0.69	-0.56

Updated Feb 26, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q